[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644538":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":12,"centralContacts":25,"locations":12,"responsibleParty":31,"collaborators":12,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":12,"enrollmentInfo":45,"targetDuration":12,"studyType":48,"phases":49,"briefSummary":51,"conditions":52,"keywords":12,"overallStatus":54,"whyStopped":12,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":12},{"fullName":5,"class":6},"Herlev Hospital","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Controlgroup","NO_INTERVENTION","Standard treatment",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention","ACTIVE_COMPARATOR","22 mg zinc supplementation daily for 12 months",[18],"Dietary Supplement: Zinc Supplement",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"DIETARY_SUPPLEMENT","Zinc Supplement","22 mg Zinc supplementation daily for 12 months",[14],[26],{"name":27,"role":28,"phone":29,"phoneExt":12,"email":30},"Cecilia M Lund, MD, PhD","CONTACT","+4538686112","cecilia.margareta.lund.01@regionh.dk",{"type":32,"investigatorFullName":33,"investigatorTitle":34,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Cecilia Margareta Lund","Associate Professor","100644538","zinc-supplementation-and-inflammation-in-older-medical-patients-100644538",false,"NCT07672132","Zinc Supplementation and Inflammation in Older Medical Patients","ZOOM IN Study: Micronutrient Deficiencies and Effect of Zinc Supplementation on Inflammation and Occurrence of Infections in Older Medical Patients (ZOOM) - A Sub-study of a Cluster Randomized Trial","ZOOM-IN","Inclusion Criteria:\n\n* above 65 years old included in ZOOM out ( clinical trials no: NCT07367412)\n* admittet at the medical emergency department Herlev Hospital\n\nExclusion Criteria:\n\n* Patients receiving zinc supplements (\\>10 mg daily) at time of inclusion\n* Patients with terminal illness (life expectancy \\\u003C 6 months, estimated by Clinical Frailty Scale ≥8)\n* Patients receiving parenteral nutrition (partial or complete)\n* Patients treated with hemodialysis or peritoneal dialysis\n* Patients known with severe dementia\n* Patients who do not understand Danish and patients with temporary civil person registration numbers (CPR)","ALL","65 Years",{"count":46,"type":47},220,"ESTIMATED","INTERVENTIONAL",[50],"NA","The hypothesis is that a daily supplement of 22 mg of zinc over 12 months can reduce in-flammatory biomarkers in acutely hospitalized older adults aged ≥ 65 years.\n\nThe aims are to determine, in acutely hospitalized older adults aged ≥ 65 years, if a daily supplement of 22 mg of zinc over 12 months compared to control can decrease inflammato-ry biomarkers, reduce symptoms of self-reported infection, reduce readmission and mortali-ty, increase QoL, increase physical performance, investigate potential adverse events to zinc supplement, and the changes in inflammatory biomarkers. It will also be studied if albumin-corrected zinc in plasma is a more accurate method for assessing zinc status than ordinary plasma zinc.",[53],"Older Medical Patients","NOT_YET_RECRUITING","2026-06-23",{"date":57,"type":58},"2026-06-26","ACTUAL",{"date":60,"type":47},"2026-06-02",{"date":62,"type":47},"2028-05-31",{"name":5,"class":6}]